Search results (6)
« Back to NewsProfessor Adam Mead joins Oxford Cancer leadership team
15 June 2026
Congratulations to Adam Mead, who has been appointed Director of Oxford Cancer. Professor Mead joins Professors Mark Middleton and Tim Elliott in leading Oxford’s interdisciplinary cancer research community.
Paresh Vyas receives CRUK Discovery Programme Award
11 March 2026
Congratulations to Professor Paresh Vyas, who has been awarded a Discovery Research grant from Cancer Research UK to investigate cancer immunotherapies.
Unravelling T-Cell Recognition: Insights from Immunology and AI
13 October 2025
From 29 September to 1 October 2025, researchers from across the world gathered in Oxford for a unique conference and hackathon exploring how advances in artificial intelligence can deepen understanding of T-cell biology.
New research reveals druggable target arising from chromosomal rearrangement in aggressive leukaemia
10 June 2025
Researchers at the University of Oxford have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.
New study finds common virus may improve skin cancer treatment outcomes
23 April 2025
A new study led by the Fairfax Group at the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.
Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research
21 February 2025
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.